Back to Journals » Journal of Hepatocellular Carcinoma » Volume 13
Artificial Intelligence and Radiomics in Primary Liver Cancer Imaging: A Bibliometric and Visualized Analysis
Authors Fu R, Gao C
, Lou X
, Han Z, He Y, Zheng C, Yu Z, Chang H
Received 3 November 2025
Accepted for publication 17 March 2026
Published 1 April 2026 Volume 2026:13 578670
DOI https://doi.org/10.2147/JHC.S578670
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Imam Waked
Ruizhi Fu,1,2,* Chen Gao,1,2,* Xinjing Lou,1,2 Ziqing Han,1,2 Yizhen He,1,2 Chenye Zheng,1,2 Zhuping Yu,3 Hongsheng Chang1,2
1Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, People’s Republic of China; 2The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 3Department of Radiology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Hongsheng Chang, Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, People’s Republic of China, Email [email protected] Zhuping Yu, Department of Radiology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of China, Email [email protected]
Background: Combining artificial intelligence (AI) with radiomics for primary liver cancer (PLC) enhances diagnostic precision, sharpens risk stratification, and facilitates personalized treatment. The study aims to conduct a bibliometric analysis of this field, explore its research status and emerging hotspots, and provide data support and academic insights for subsequent research.
Methods: A bibliometric analysis of 2890 publications on PLC, AI, and radiomics from 2008 to 2025 was performed, using data retrieved from the Web of Science Core Collection (WoSCC) and Scopus, followed by manual screening and deduplication. The finalized dataset was analyzed and visualized using tools such as VOSviewer, CiteSpace, and R to examine trends in annual publication counts, the geographic distribution of research, the institutions involved, journals, authors, references, and keywords.
Results: Publication output has increased rapidly since 2018. China (n = 1603, 55.47%) was the leading contributor, and Sun Yat-sen University (n = 186, 6.44%) was the most productive institution. Of all authors, Song, Bin (n = 42) was the most prolific author. Frontiers in Oncology and Radiology were identified as the most productive and influential journals, respectively. The most frequently occurring keywords were “hepatocellular carcinoma”, “deep learning”, and “magnetic resonance imaging”, while “image reconstruction”, “liver cancer classification”, and “deep supervision” have emerged as prominent recent research hotspots.
Conclusion: Applications of AI and radiomics in imaging for PLC are gaining increasing attention. Future trends are expected to focus on enhancing algorithmic accuracy and advancing clinical prediction of microvascular invasion, postoperative outcomes after hepatectomy, and the effectiveness of transarterial chemoembolization.
Keywords: liver neoplasms, hepatocellular carcinoma, artificial intelligence, radiomics, bibliometrics
Introduction
Primary liver cancer (PLC) is one of the most common malignant tumors in the digestive system and the leading cause of death from cancer worldwide.1 The main pathological types include hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma, among which HCC is the most common.2 According to the 2022 Global Cancer Statistics, the incidence of PLC (4.3%) and mortality (7.8%) rank sixth and third in cancer worldwide, posing a serious threat to public health.3 Due to the lack of reliable early warning signs, most patients have progressed to the intermediate and advanced stages at the time of diagnosis, resulting in limited treatment options and poor prognosis.4,5
Medical imaging plays a key role in the diagnosis and treatment of PLC, thereby improving early detection and clinical decision-making.6 Although ultrasound remains the primary screening tool due to its practicality, computed tomography (CT) and magnetic resonance imaging (MRI) provide more detailed tumor information thanks to their superior spatial resolution and tissue contrast.7–9 However, traditional imaging techniques have limitations in detecting small lesions and in differentiating benign from malignant masses.10,11
To address these limitations, artificial intelligence (AI)-integrated radiomics has significantly advanced the accurate diagnosis and treatment of PLC.12 By quantifying tumor texture and morphology, radiomics has revealed phenotypic heterogeneity and microenvironmental characteristics, providing an objective basis for clinical management.13 Although traditional radiomics faces challenges such as high-dimensional data and complex workflows, the integration of deep learning (DL) and machine learning (ML) has effectively simplified the process of feature extraction and analysis.14–16 Specifically, convolutional neural network (CNN) models leverage their powerful pattern-recognition capabilities to process multidimensional data, achieving high-precision classification and improving efficiency.17,18 This synergy has led the research to shift from empirical methods to data-driven precision medicine, which has demonstrated significant achievements in lesion differentiation, microvascular invasion (MVI) prediction, and recurrence risk assessment.19–21 Furthermore, the rapid growth of multi-omics is expanding this paradigm. The synergy between AI and multidimensional data enables characterization of the PLC phenomenon, bridging macroscopic imaging with microscopic molecular landscapes to enhance precision medicine.22 Recent molecular studies have further elucidated the biological basis underlying imaging phenotypes in PLC, including key regulatory genes, microRNA networks, and potential therapeutic targets, which provide complementary insights for radiomics and AI-based precision diagnosis and treatment.23–26
Due to the rapid growth of radiomics and AI in PLC diagnosis and treatment, it’s challenging for a systematic review to fully grasp research trends. Bibliometrics, as a method for analyzing academic literature both qualitatively and quantitatively, can objectively reflect the development of the field by analyzing indicators such as annual output and key authors. It also compensates for the shortcomings of quantitative analysis in systematic reviews.27,28 Although many bibliometric studies on liver cancer exist, a comprehensive bibliometric analysis of this interdisciplinary field is still lacking.29,30
Therefore, this study employs bibliometric methods to systematically analyze the literature on PLC, radiomics, and AI. By analyzing annual publication output, key countries and institutions, leading authors, core journals, highly cited papers, and keyword trends, the study objectively uncovers the field’s developmental path, research trends, and future directions, offering insights for future research.
Materials and Methods
Data Sources and Search Strategies
The complete process from initial literature search to data visualization analysis is shown in Figure 1. Our data are obtained from the Science Citation Index Extended Edition of the Web of Science Core Collection (WoSCC) and the Scopus databases. In WoSCC, the search was conducted using Topic (TS) to search AI, radiomics, PLC, CT, MRI, and other related terms. In Scopus, the search was performed using the TITLE-ABS-KEY field for the same set of terms. The search strategy is detailed in Appendix 1 of the Supplementary Materials. The literature search scope is limited to English-language articles and reviews. The time span is from January 1, 2008, to December 31, 2025, incorporating Early Access content. After collecting all publications, two authors (RZF and CG) independently screened the titles and abstracts of the retrieved records and conducted a cross-review for a second round of verification. Any controversies or inconclusive publications were resolved by two experienced radiologists (ZPY and HSC).
|
Figure 1 Flowchart of literature sources, screening, and data visualization analysis. |
Data Collection and Processing
Following the above screening process, 1874 and 2594 eligible publications were identified from WoSCC and Scopus, respectively. Complete information, including the title, author, abstract, keywords, and references, was extracted from the marked result list of the WoSCC and converted to a plain-text file for export. For Scopus, records were obtained from the marked result list and exported in “CSV with All Fields” format. Using Python (version 3.11), the CSV files from Scopus and the TXT files from WoSCC were converted into a unified plain-text format that is consistent with the complete records and citation reference structure of WoSCC. Firstly, data cleaning was carried out to ensure data quality, including deduplication of the same Digital Object Identifiers, exclusion of withdrawn publications, and exclusion of records in which the author field contains “[Anonymous]”. Secondly, the institutional data were optimized by eliminating virtual institutions and by standardizing and merging duplicate institutions. Finally, a manual review was conducted. After this process, a total of 2890 publications were included in the analysis.
Visualization and Data Presentation
Data management and preliminary statistical analysis, including visualization of annual publication trends and literature types, were conducted using Microsoft Excel 2021. For more advanced bibliometric visualization, the appropriate tool should be selected based on its analytical advantages. VOSviewer (version 1.6.20) was used to draw the network of collaborations between countries/regions and institutions as well as the network diagram of co-cited journals. To enhance the graphical presentation, Pajek (version 6.01) was used to optimize the layout of network nodes, while Scimago Graphica (version 1.0.53) was integrated to generate a world map to display international cooperation.31 CiteSpace (version 6.4.R1 Advanced) was used for studying temporal dynamics and research frontiers. This included generating chronological diagrams of author collaborations and evolution diagrams of keywords, a dual-map overlay of journals, and capturing references and keywords exhibiting strong citation bursts over time.32 Additionally, the log-likelihood ratio (LLR) algorithm in CiteSpace was used for cluster analysis of co-cited references to identify emerging trends, while the R software (version 4.5.2) package ggplot2 was used for visualizing specific journal indicators.
Results
Annual Publications and Trend
Publication volume signifies research activity. Figure 2A illustrates that between 2008 and 2018, the annual publication count remained low, not exceeding 77. Since 2018, the number of publications has increased significantly, accounting for approximately 80% of total publications from 2020 to 2025. To quantify this nonlinear acceleration trend, Figure 2A employs a cubic polynomial fit. The R2 = 0.9881 indicates a good fit. The overall growth trend is clear, and it is still on the rise. Specifically for the types of literature (Figure 2B), the number of Articles has consistently been the largest and has increased rapidly, in line with the overall trend. Although the base for Reviews is relatively small, it has increased in parallel since 2018.
Analysis of Countries/Regions
Figure 3A shows cooperation among countries and the total number of publications from major countries. Correspondingly, Table 1 lists the top 15 countries by the number of publications and their citation and collaboration indicators. China is the most productive country (n = 1603, 55.47%), followed by the USA (n = 538, 18.62%). Although China and the USA maintain certain cooperation, China’s scientific research output remains primarily driven by domestic collaboration, comprising 1331 single-country publications. In contrast, the multi-country publication ratios in Saudi Arabia, Switzerland, and the United Kingdom all exceed 80% (Table 1). In terms of influence, China achieved the highest total citations (TC = 30,773) due to its substantial publication volume, yet its average citations per literature (AC = 19.20) was relatively low. Notably, although the Netherlands had fewer publications (n = 45), its AC (40.93) was high.
|
Table 1 The Top 15 Most Productive Countries in AI and Radiomics for PLC |
Analysis of Institutions
Chinese institutions led PLC, AI, and radiomics research (Table S1). Sun Yat-sen University is a leading contributor (n = 186, 6.44%) to DL radiomics for HCC. Meanwhile, Stanford University demonstrated strong academic influence, with an average of 45.61 citations. GE Healthcare (n = 73) was the only enterprise organization in the top 20. Figure 3B shows 10 different clusters based on inter-agency collaboration. Figure 3C further illustrates a significant increase in recent activities, with major Chinese universities, such as Sun Yat-sen University and Zhejiang University, strengthening their cooperation efforts since 2022. While cross-border cluster cooperation mostly occurred before 2022.
Analysis of Journals
Statistics were compiled for the top 30 journals in the field by publication volume to examine the relationships among publication count, TC, and impact factor (IF), yielding Figure 4A. The findings revealed that fourteen journals had published more than 40 relevant articles. Among these, European Radiology had the highest TC (4307), while Radiology possessed the highest IF (15.2) (Table S2). Frontiers in Oncology contributed the most publications (n = 148, H-index = 28), followed by Abdominal Radiology (n = 92, H-index = 22) and European Radiology (n = 88, H-index = 36) (Table S2).
To better understand how journals are interconnected, the co-citation network was analyzed. Figure 4B indicates close interdisciplinary integration among radiology, hepatology, surgery, oncology, and computational medicine and image processing. The significant co-citation connections suggest frequent knowledge sharing among these fields. This is further supported by the dual-map overlay (Figure 4C), which shows that research published relies heavily on the fields of health, nursing, medicine, molecular, biology, and genetics. Additionally, disciplines such as systems, computing, and computer science also contribute to PLC, AI, and radiomics research.
Analysis of the Authors
According to Price’s Law, authors who publish at least five articles can be regarded as core authors. There are 497 core authors in this research field, and the 10 most productive authors are shown in Table S3. Meanwhile, the most cited authors are also listed (Table S4). From the timeline of author cooperation (Figure 5A), it is evident that the authors within each cluster cooperate closely, whereas links between clusters are relatively small. The three main author clusters identified were “learning radiomics (#0)”, “intrahepatic cholangiocarcinoma (#1)”, and “preoperative gadoxetic acid-enhanced mri (#2)”. Notably, Song, Bin, the most prolific author, is situated within cluster #1, with his research output primarily concentrated in the period following 2019.33,34 Figure 5B shows the co-cited network diagram of authors. The top three authors with influence in this field are Professor Hyuna Sung of the USA, Professor Philippe Lambin of the Netherlands, and Professor Josep M. Llovet of Spain.
Analysis of References and Co-Cited References
The 15 papers with the highest citation frequency were listed in Table 2, along with their respective publication venues.35–49 Notably, Li Xiaomeng’s team published a paper on H-Dense U-Net in IEEE Transactions on Medical Imaging in 2018, which ranks first with 1785 citations.35 The co-citation network divides highly cited papers into 12 clusters (Figure 5C), covering topics such as AI, texture analysis, clinical PLC diagnosis and treatment. Among these, “radiomics (#0)” is currently the largest cluster. Multiple clusters jointly promote their research progress. When combined with burst citation analysis (Figure 5D), Gillies et al reported a very strong citation burst (Strength = 41.40).35,38,50–67 The papers published by Li Xiaomeng, Jorge A. Marrero, and Julie K. Heimbach have been highly cited in recent years.35,66,67
|
Table 2 Top 15 Most Cited Papers on AI and Radiomics in PLC |
Keywords and Hotspots Analysis
When keyword analysis was performed on the research literature of AI and radiomics in PLC field, a co-occurrence network was constructed based on the keywords after merging (Figure 6A). The keywords that appeared more than 200 times included “hepatocellular carcinoma”, “deep learning”, “magnetic resonance imaging”, “machine learning”, “computed tomography”, and “artificial intelligence”. Detailed data and centrality metrics for the top 25 keywords are presented in Table S5.
To further understand the evolution trend of research hotspots, the keywords in the timeline analysis revealed 11 main clusters (Figure 6B). This timeline shows that the research context starts from basic image processing, and then, with the rise and continuous development of AI, the research topic shifted to clinical problems directly related to PLC. In the past three years, “image reconstruction”, “liver cancer classification”, and “deep supervision” have become prominent terms (Figure 6C).
Discussion
This study analyzed 2890 publications from the WoSCC and Scopus databases related to AI and radiomics in PLC imaging through a systematic bibliometric review. Since 2018, the significant growth in publications can be attributed to multiple factors. The influential paper “Radiomics: the bridge between medical imaging and personalized medicine”, published in 2017 by Philippe Lambin, an influential author in the field, played a significant role in popularizing the concept of radiomics.58 Furthermore, the launch of the Image Biomarker Standardization Initiative (IBSI) and the American College of Radiology’s ongoing updates to the Liver Imaging Reporting and Data System (LI-RADS) may have also contributed to accelerating the field’s rapid development.68,69
At the national and regional levels, China produced the highest number of publications, and Chinese institutions also led research in this area. This is closely linked to the historically high incidence of liver cancer in China.70 However, there remains a gap in citations per article when compared to European and American research countries. The potential reasons are as follows: Firstly, this gap is closely related to the dominant position that Western institutions hold in the global academic network. Research from European and American institutions is often published in high-impact academic journals.71,72 These journals have significantly higher H-index and IF, which reflect their central position within the global academic network. Their dissemination channels are also more extensive, which may enable articles published in these journals to accrue citations over time. Secondly, European and American countries have abundant academic resources and face lower barriers to collaboration and exchange, enabling them to produce valuable research findings.73,74 The high rate of multinational collaboration in these regions, compared to lower levels in Asian countries, further supports this observation.
The relatively low level of international collaboration among Asian countries may stem from differences in disease causes and communication costs. The high rate of hepatitis B virus-related liver cancer in Asia and the prevalence of alcoholic hepatitis in the West differ in their pathogenesis and treatment strategies.75,76 These differences also hinder the development of common ground for collaboration between the two regions parties. Furthermore, the varied language backgrounds across Asia impede complicate and exchanges between countries, limiting academic collaboration both within and between regions. These issues have somewhat obstructed the development of a global research network.
Radiology is an important journal in this field due to its high IF and disciplinary reputation. Additionally, IEEE Transactions on Medical Imaging and Medical Physics appear in the co-citation network, reflecting the close integration of medicine and engineering. The core authors have a close network of collaborations, but international collaboration among authors requires strengthening. The high number of sudden citations indicates the primary developmental thread in this field. The focus of the research has shifted from the initial image-based analytics and AI algorithms to clinical applications. The keyword analysis in CiteSpace identified two main research hotspots: technological advancements in radiomics methods and their clinical applications in PLC-related tasks. These hotspots highlight the potential of integrating AI with radiomics in improving the management of PLC.
In the era of medical big data, “liver tumor segmentation” has emerged as the largest topic cluster in AI and radiomics keyword clustering within the PLC field, reflecting a significant and sustained publication trend. AI methods in PLC radiomics have undergone a significant paradigm shift, reflecting higher-level integration of technological advancements.77 While early traditional ML techniques like k-nearest neighbor, logistic regression, support vector machine, and random forest have served as fundamental components in traditional segmentation pipelines, they face limitations due to reliance on handcrafted features, sensitive parameter settings, and difficulty handling large-scale data.78–80 Since the advent of DL, CNNs have emerged as the dominant approach, effectively overcoming the limitations of manual feature engineering by directly learning complex patterns from raw data.81,82 The U-Net introduced by Ronneberger et al83 is an important CNN-based network widely applied to liver and tumor segmentation.84 The results of the bibliometric analysis show that articles on U-Net variants, especially for HCC image segmentation, have received a large number of citations, highlighting their wide application and significant influence in addressing challenges such as blurred boundaries and small lesions.42,85,86 Recently, models based on Transformers have emerged in this field, such as Vision Transformer, Swin Transformer, and Segment Anything Model (SAM). These models have stronger capabilities for capturing long-range dependencies and for performing segmentation with less amount of labeled data.87 This systematic progression from manual features to CNNs, to models based on Transformer, and to foundational models like SAM, highlights the dynamic nature of AI’s continuous breakthroughs in PLC diagnosis and management.
In this context, the potential of AI and radiomics in the clinical application of PLC remains an area of active exploration. Most studies have focused on challenges such as distinguishing uncertain nodules, pathologic grading, and predicting MVI, underscoring the potential value of AI and radiomics in diagnosing PLC.88–90 Additionally, research has explored individualized treatment evaluation, including the assessment of preoperative transarterial chemoembolization (TACE) efficacy and the prediction of immunotherapy outcomes.91,92 Positive results in modeling postoperative recurrence and survival outcomes further highlight AI and radiomics promising role in risk stratification and follow-up management.93,94
Despite these advancements, the clinical application of AI and radiomics in PLC remains significantly constrained by methodological and technical limitations.95,96 Besides inherent limitations such as small sample sizes and scarce external validations, the insufficient stability and reproducibility of features remain key challenges.95,97,98 The radiomics features are highly sensitive to variations in imaging scanners, acquisition parameters, reconstruction algorithms, and feature extraction software.96,99 Such cross-scanner differences, combined with inter-observer variability, severely hinder the general applicability of radiomics models in multicenter and real-world clinical settings.100 It is notable that the establishment and promotion of standardized frameworks like the IBSI have significantly improved the consistency in the feature extraction process.68
Furthermore, recent keyword burst analysis has revealed related methods such as “image reconstruction”, “liver cancer classification”, and “deep supervision”, suggesting that research focus may be gradually shifting toward improving quantification and interpretability. Although the specific keyword “multimodal fusion” did not emerge as a prominent hotspot in the cluster analysis, the terms “feature fusion (#10)” and those related to imaging technologies, texture analysis, and clinical integration were identified. This suggests a potential trend toward integrating multiple sources of information. Recent literature has shown that combining radiological images with clinical data, pathology, or genomics can significantly improve diagnostic accuracy and prognostic stratification.96,101 However, such integration methods require rigorous validation to ensure that the increase in model complexity can achieve effective clinical translation.96 Based on these constantly changing trends, future research in the PLC field is likely to focus on standardizing methods and developing a multi-modal framework that can effectively integrate radiological imaging with multi-source clinical information.
Compared with the focused analysis conducted by Teng et al102 (n = 906), our study adopted a broader perspective and analyzed 2890 studies. Teng et al conducted a detailed study of core radiomics workflow in HCC, whereas our analysis focuses on the interdisciplinary integration of AI into PLC. Our keyword analysis highlighted key technological trends like “CNNs” and “deep supervision”, which were less emphasized in earlier bibliometric studies. However, our broader view might limit depth in certain specialized areas. Additionally, although our study tracks the evolution of AI technology over time, the field’s fast-paced innovations may not be fully captured, and recent developments might be underrepresented. Future research combining detailed specialized analysis with comprehensive bibliometric approaches could yield more precise insights into specific technologies or clinical issues.
There are several limitations in this study. First, our study uses the WoSCC and Scopus databases and includes only English literature, restricted to article and review document types. This approach may overlook relevant research findings. Second, although the search strategy, duplication, and synonym normalization cleaning processes have been checked, it remains difficult to eliminate topic drift and label bias. Third, the parameter settings of CiteSpace and VOSviewer affect the network’s sparsity and clustering stability to some extent. Fourth, the inability to accurately retrieve the annual citation count for each document from the existing metadata limits the ability to conduct a more detailed assessment of citation influence over time. Nevertheless, the results of our analysis adequately reflect the overall situation in the field.
Conclusion
This bibliometric study highlights the rapid expansion of global research on AI and radiomics in PLC imaging over the past 18 years, emphasizing a shift from methodological exploration to practical application. The analysis indicates that MVI prediction, TACE treatment response, and prognosis prediction are the main research hotspots in the current literature. These findings depict the evolving knowledge landscape in this field and point the way for subsequent academic research, emphasizing the necessity of maintaining sustained attention to these relevant active research areas.
Abbreviations
AI, Artificial intelligence; WoSCC, Web of Science Core Collection; PLC, Primary liver cancer; HCC, Hepatocellular carcinoma; CT, Computed tomography; MRI, Magnetic resonance imaging; DL, Deep learning; ML, Machine learning; CNN, Convolutional neural network; AC, Average citations; TC, Total citations; IF, Impact factor; MVI, Microvascular invasion; TACE, Transarterial chemoembolization; IBSI, Image Biomarker Standardization Initiative; LI-RADS, Liver Imaging Reporting and Data System; SAM, Segment Anything Model.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–16. doi:10.1016/j.jhep.2022.08.021
2. Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of primary liver cancer (2022 Edition). Liver Cancer. 2023;12(5):405–444. doi:10.1159/000530495
3. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. doi:10.3322/caac.21834
4. Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362. doi:10.1016/S0140-6736(22)01200-4
5. Dadrass F, Sher A, Kim E. Update on locoregional therapies for liver cancer: radiation segmentectomy. Curr Oncol. 2023;30(12):10075–10084. doi:10.3390/curroncol30120732
6. Hwang SY, Danpanichkul P, Agopian V, et al. Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment. Clin Mol Hepatol. 2025;31(Suppl):S228–S254. doi:10.3350/cmh.2024.0824
7. Daher D, Seif El Dahan K, Cano A, et al. Hepatocellular carcinoma surveillance patterns and outcomes in patients with cirrhosis. Clin Gastroenterol Hepatol. 2024;22(2):295–304.e2. doi:10.1016/j.cgh.2023.08.003
8. Qiao S, Xue M, Zuo Y, et al. Four-phase CT lesion recognition based on multi-phase information fusion framework and spatiotemporal prediction module. Biomed Eng Online. 2024;23(1):103. doi:10.1186/s12938-024-01297-x
9. Vogel A, Chan SL, Dawson LA, et al. Hepatocellular carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36(5):491–506. doi:10.1016/j.annonc.2025.02.006
10. Zhao T, Zeng Z, Li T, et al. USC-ENet: a high-efficiency model for the diagnosis of liver tumors combining B-mode ultrasound and clinical data. Health Inf Sci Syst. 2023;11(1):15 doi:10.1007/s13755-023-00217-y
11. Afyouni S, Zandieh G, Nia IY, Pawlik TM, Kamel IR. State-of-the-art imaging of hepatocellular carcinoma. J Gastrointest Surg. 2024;28(10):1717–1725. doi:10.1016/j.gassur.2024.08.001
12. Dimopoulos P, Mulita A, Antzoulas A, et al. The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review. Prz Gastroenterol. 2024;19(3):221–230. doi:10.5114/pg.2024.143147
13. Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446. doi:10.1016/j.ejca.2011.11.036
14. Liu Z, Wang S, Dong D, et al. The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges. Theranostics. 2019;9(5):1303–1322. doi:10.7150/thno.30309
15. Xu Y, Zheng B, Liu X, et al. Improving artificial intelligence pipeline for liver malignancy diagnosis using ultrasound images and video frames. Brief Bioinform. 2023;24(1):bbac569. doi:10.1093/bib/bbac569
16. Moroney J, Trivella J, George B, White SB. A paradigm shift in primary liver cancer therapy utilizing genomics, molecular biomarkers, and artificial intelligence. Cancers. 2023;15(10):2791. doi:10.3390/cancers15102791
17. Azer SA. Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: a systematic review. World J Gastrointest Oncol. 2019;11(12):1218–1230. doi:10.4251/wjgo.v11.i12.1218
18. Yamada A, Oyama K, Fujita S, et al. Dynamic contrast-enhanced computed tomography diagnosis of primary liver cancers using transfer learning of pretrained convolutional neural networks: is registration of multiphasic images necessary? Int J Comput Assist Radiol Surg. 2019;14(8):1295–1301. doi:10.1007/s11548-019-01987-1
19. Hu HT, Wang W, Chen LD, et al. Artificial intelligence assists identifying malignant versus benign liver lesions using contrast-enhanced ultrasound. J Gastroenterol Hepatol. 2021;36(10):2875–2883. doi:10.1111/jgh.15522
20. Wang F, Zhan G, Chen QQ, et al. Multitask deep learning for prediction of microvascular invasion and recurrence-free survival in hepatocellular carcinoma based on MRI images. Liver Int. 2024;44(6):1351–1362. doi:10.1111/liv.15870
21. Yan M, Zhang X, Zhang B, et al. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy. Eur Radiol. 2023;33(7):4949–4961. doi:10.1007/s00330-023-09419-0
22. Ying W. Phenomic studies on diseases: potential and challenges. Phenomics. 2023;3(3):285–299. doi:10.1007/s43657-022-00089-4
23. Gudivada IP, Amajala KC. Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment. Curr Genomics. 2025;26(1):48–80. doi:10.2174/0113892029308243240709073945
24. Xu W, Liao S, Hu Y, Huang Y, Zhou J. Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1: miR-3130-5p enhances HCC growth via inhibiting FDX1. Curr Mol Pharmacol. 2024;17:e18761429358008 doi:10.2174/0118761429358008250305070518.
25. Qian J, Jiang B, Qin Z, Tan Y. Knockdown of hsa_circ_0102231 impedes the progression of liver cancer through the miR-873-SOX4 Axis. Curr Gene Ther. 2025;25(3):317–326. doi:10.2174/0115665232301878240627051455
26. Hajinourmohammadi A, Zargan J, Jafary H, Ebrahimi F. Evaluation of the anti-liver cancer activity of protein fractions isolated from adenium obesum leaf extract. Protein Pept Lett. 2025;32(10):742–755 doi:10.2174/0109298665411024251015093155.
27. Thompson DF, Walker CK. A descriptive and historical review of bibliometrics with applications to medical sciences. Pharmacotherapy. 2015;35(6):551–559. doi:10.1002/phar.1586
28. Ninkov A, Frank JR, Maggio LA. Bibliometrics: methods for studying academic publishing. Perspect Med Educ. 2022;11(3):173–176. doi:10.1007/S40037-021-00695-4
29. Han H, Zhao Z, He M, et al. Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis. Front Immunol. 2024;15:1474869. doi:10.3389/fimmu.2024.1474869
30. He T, Zou J, Sun K, Yang J. Global research status and frontiers on autophagy in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis. Int J Surg. 2024;110(5):2788–2802. doi:10.1097/JS9.0000000000001202
31. Hassan-Montero Y, De-Moya-Anegón F, Guerrero-Bote VP. SCImago graphica: a new tool for exploring and visually communicating data. El Profesional de la información. 2022;31(5):e310502. doi:10.3145/epi.2022.sep.02
32. Chen C, Hu Z, Liu S, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. 2012;12(5):593–608. doi:10.1517/14712598.2012.674507
33. Zhang Z, Jiang H, Chen J, et al. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer Imaging. 2019;19(1):22. doi:10.1186/s40644-019-0209-5
34. Zhang J, Wu Z, Zhang X, et al. Machine learning: an approach to preoperatively predict PD-1/PD-L1 expression and outcome in intrahepatic cholangiocarcinoma using MRI biomarkers. ESMO Open. 2020;5(6):e000910. doi:10.1136/esmoopen-2020-000910
35. Li X, Chen H, Qi X, Dou Q, Fu CW, Heng PA. H-DENSEUNET: hybrid densely connected UNet for liver and tumor segmentation from CT volumes. IEEE Trans Med Imaging. 2018;37(12):2663–2674. doi:10.1109/TMI.2018.2845918
36. Bilic P, Christ P, Li HB, et al. The liver tumor segmentation benchmark (LiTS). Med Image Anal. 2023;84:102680. doi:10.1016/j.media.2022.102680
37. Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70(6):1133–1144. doi:10.1016/j.jhep.2019.02.023
38. Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology. 2018;286(3):887–896. doi:10.1148/radiol.2017170706
39. Li X, Yu L, Chen H, Fu CW, Xing L, Heng PA. Transformation-consistent self-ensembling model for semisupervised medical image segmentation. IEEE Trans Neural Netw Learn Syst. 2021;32(2):523–534. doi:10.1109/TNNLS.2020.2995319
40. Seo H, Huang C, Bassenne M, Xiao R, Xing L. Modified U-net (mU-Net) with incorporation of object-dependent high level features for improved liver and liver-tumor segmentation in CT images. IEEE Trans Med Imaging. 2020;39(5):1316–1325. doi:10.1109/TMI.2019.2948320
41. Fan T, Wang G, Li Y, Wang H. MA-net: a multi-scale attention network for liver and tumor segmentation. IEEE Access. 2020;8:179656–179665. doi:10.1109/ACCESS.2020.3025372
42. Jin Q, Meng Z, Sun C, Cui H, Su R. RA-UNet: a hybrid deep attention-aware network to extract liver and tumor in CT scans. Front Bioeng Biotechnol. 2020;8:605132. doi:10.3389/fbioe.2020.605132
43. van der Pol CB, Lim CS, Sirlin CB, et al. Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy-a systematic review. Gastroenterology. 2019;156(4):976–986. doi:10.1053/j.gastro.2018.11.020
44. Weston AD, Korfiatis P, Kline TL, et al. Automated abdominal segmentation of CT scans for body composition analysis using deep learning. Radiology. 2019;290(3):669–679. doi:10.1148/radiol.2018181432
45. Liu L, Cheng J, Quan Q, Wu F-X, Wang Y-P, Wang J. A survey on U-shaped networks in medical image segmentations. Neurocomputing. 2020;409:244–258. doi:10.1016/j.neucom.2020.05.070
46. Chang Y, Jeong SW, Young Jang J, Jae Kim Y. Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma. Int J Mol Sci. 2020;21(21):8165. doi:10.3390/ijms21218165
47. Yang L, Gu D, Wei J, et al. A radiomics nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Liver Cancer. 2019;8(5):373–386. doi:10.1159/000494099
48. Hamm CA, Wang CJ, Savic LJ, et al. Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI. Eur Radiol. 2019;29(7):3338–3347. doi:10.1007/s00330-019-06205-9
49. Ji GW, Zhu FP, Xu Q, et al. Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional study. Radiology. 2020;294(3):568–579. doi:10.1148/radiol.2020191470
50. Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. doi:10.1038/ncomms5006
51. Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577. doi:10.1148/radiol.2015151169
52. Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology. 2015;62(3):792–800. doi:10.1002/hep.27877
53. Renzulli M, Brocchi S, Cucchetti A, et al. Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiology. 2016;279(2):432–442. doi:10.1148/radiol.2015150998
54. Christ PF, Elshaer MEA, Ettlinger F, et al. Automatic liver and lesion segmentation in CT using cascaded fully convolutional neural networks and 3D conditional random fields. In:
55. Zhou Y, He L, Huang Y, et al. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol. 2017;42(6):1695–1704. doi:10.1007/s00261-017-1072-0
56. Zhou W, Zhang L, Wang K, et al. Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images. J Magn Reson Imaging. 2017;45(5):1476–1484. doi:10.1002/jmri.25454
57. Lee S, Kim SH, Lee JE, Sinn DH, Park CK. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. 2017;67(3):526–534. doi:10.1016/j.jhep.2017.04.024
58. Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–762. doi:10.1038/nrclinonc.2017.141
59. van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104–e107. doi:10.1158/0008-5472.CAN-17-0339
60. Litjens G, Kooi T, Bejnordi BE, et al. A survey on deep learning in medical image analysis. Med Image Anal. 2017;42:60–88. doi:10.1016/j.media.2017.07.005
61. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
62. Sun C, Guo S, Zhang H, et al. Automatic segmentation of liver tumors from multiphase contrast-enhanced CT images based on FCNs. Artif Intell Med. 2017;83:58–66. doi:10.1016/j.artmed.2017.03.008
63. Peng J, Zhang J, Zhang Q, Xu Y, Zhou J, Liu L. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. Diagn Interv Radiol. 2018;24(3):121–127. doi:10.5152/dir.2018.17467
64. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
65. Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370. doi:10.1007/s12072-017-9799-9
66. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68(2):723–750. doi:10.1002/hep.29913
67. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
68. Zwanenburg A, Vallieres M, Abdalah MA, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295(2):328–338. doi:10.1148/radiol.2020191145
69. Chernyak V, Fowler KJ, RKG D, et al. LI-RADS: looking back, looking forward. Radiology. 2023;307(1):e222801. doi:10.1148/radiol.222801
70. Zhan Z, Chen B, Huang R, et al. Long-term trends and future projections of liver cancer burden in China from 1990 to 2030. Sci Rep. 2025;15(1):13120. doi:10.1038/s41598-025-96615-1
71. Hsieh C, Laguna A, Ikeda I, et al. Using machine learning to predict response to image-guided therapies for hepatocellular carcinoma. Radiology. 2023;309(2):e222891. doi:10.1148/radiol.222891
72. Calderaro J, Zigutyte L, Truhn D, Jaffe A, Kather JN. Artificial intelligence in liver cancer - new tools for research and patient management. Nat Rev Gastroenterol Hepatol. 2024;21(8):585–599. doi:10.1038/s41575-024-00919-y
73. Gross M, Haider SP, Ze’evi T, et al. Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning. Eur Radiol. 2024;34(10):6940–6952. doi:10.1007/s00330-024-10624-8
74. Said D, Carbonell G, Stocker D, et al. Semiautomated segmentation of hepatocellular carcinoma tumors with MRI using convolutional neural networks. Eur Radiol. 2023;33(9):6020–6032. doi:10.1007/s00330-023-09613-0
75. Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–683. doi:10.1016/j.jhep.2018.12.001
76. Wen B, Te L, Bai C, et al. Relative contribution of hepatitis B and C viruses in primary liver cancer in China: a systematic review and meta-analysis. J Infect. 2024;89(6):106298. doi:10.1016/j.jinf.2024.106298
77. Larrain C, Torres-Hernandez A, Hewitt DB. Artificial intelligence, machine learning, and deep learning in the diagnosis and management of hepatocellular carcinoma. Livers. 2024;4:36–50. doi:10.3390/livers4010004
78. Mao B, Ma J, Duan S, Xia Y, Tao Y, Zhang L. Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics. Eur Radiol. 2021;31(7):4576–4586. doi:10.1007/s00330-020-07562-6
79. Zhou LQ, Wang JY, Yu SY, et al. Artificial intelligence in medical imaging of the liver. World J Gastroenterol. 2019;25(6):672–682. doi:10.3748/wjg.v25.i6.672
80. Chen L, Song H, Wang C, et al. Liver tumor segmentation in CT volumes using an adversarial densely connected network. BMC Bioinformatics. 2019;20(Suppl 16):587. doi:10.1186/s12859-019-3069-x
81. Kour T, Raina JK, Gondhi NK, et al. Transformative impact of deep learning and machine learning in oncology: a comprehensive review of AI-based approaches for early detection, diagnosis and therapeutics across different cancer types. Arch Computat Methods Eng. 2025. doi:10.1007/s11831-025-10401-w
82. Granata V, Fusco R, Setola SV, et al. An update of AI and radiomics in precision oncology: insights from liver tumors as case models. Technol Cancer Res Treat. 2025;24:15330338251387928. doi:10.1177/15330338251387928
83. Ronneberger O, Fischer P, Brox T. U-net: convolutional networks for biomedical image segmentation. In:
84. Chartrand G, Cheng PM, Vorontsov E, et al. Deep learning: a primer for radiologists. Radiographics. 2017;37(7):2113–2131. doi:10.1148/rg.2017170077
85. Ling Y, Wang Y, Dai W, Yu J, Liang P, Kong D. MTANet: multi-task attention network for automatic medical image segmentation and classification. IEEE Trans Med Imaging. 2024;43(2):674–685. doi:10.1109/TMI.2023.3317088
86. Liu Z, Hou J, Pan X, Zhang R, Shi Z. PA-net: a phase attention network fusing venous and arterial phase features of CT images for liver tumor segmentation. Comput Methods Programs Biomed. 2024;244:107997. doi:10.1016/j.cmpb.2023.107997
87. Abdoli N, Sadri Y, Gilley P, Zhang KE, Chen Y, Qiu Y. From CNNs to SAM: a survey of deep learning techniques for liver tumor segmentation in CT images. IEEE Access. 2025;13:199074–199104. doi:10.1109/ACCESS.2025.3631322
88. Zhong X, Guan T, Tang D, et al. Differentiation of small (</= 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm. BMC Gastroenterol. 2021;21(1):155. doi:10.1186/s12876-021-01710-y
89. Ren S, Qi Q, Liu S, et al. Preoperative prediction of pathological grading of hepatocellular carcinoma using machine learning-based ultrasomics: a multicenter study. Eur J Radiol. 2021;143:109891. doi:10.1016/j.ejrad.2021.109891
90. Chong HH, Yang L, Sheng RF, et al. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma </= 5 cm. Eur Radiol. 2021;31(7):4824–4838. doi:10.1007/s00330-020-07601-2
91. Zhang K, Zhang L, Li WC, et al. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients’ benefit from postoperative adjuvant TACE: a multi-center study. Eur Radiol. 2023;33(12):8936–8947. doi:10.1007/s00330-023-09824-5
92. Xu B, Dong SY, Bai XL, et al. Tumor radiomic features on pretreatment MRI to predict response to lenvatinib plus an Anti-PD-1 antibody in advanced hepatocellular carcinoma: a multicenter study. Liver Cancer. 2023;12(3):262–276. doi:10.1159/000528034
93. Wakiya T, Ishido K, Kimura N, et al. CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma. Sci Rep. 2022;12(1):8428. doi:10.1038/s41598-022-12604-8
94. Liu Y, Wei X, Zhang X, Pang C, Xia M, Du Y. CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy. Transl Oncol. 2022;26:101536. doi:10.1016/j.tranon.2022.101536
95. Sweta K, Dkhar W, Kadavigere R, et al. Diagnostic accuracy of computed tomography (CT)-based radiomics and artificial intelligence (AI) models in hepatocellular carcinoma: a systematic review and meta-analysis. Clin Radiol. 2025;89:107042. doi:10.1016/j.crad.2025.107042
96. Siam A, Alsaify AR, Mohammad B, Biswas MR, Ali H, Shah Z. Multimodal deep learning for liver cancer applications: a scoping review. Front Artif Intell. 2023;6:1247195. doi:10.3389/frai.2023.1247195
97. Romeo M, Dallio M, Napolitano C, et al. Clinical applications of Artificial Intelligence (AI) in human cancer: is it time to update the diagnostic and predictive models in managing Hepatocellular Carcinoma (HCC)? Diagnostics. 2025;15(3):252. doi:10.3390/diagnostics15030252
98. Pallumeera M, Giang JC, Singh R, Pracha NS, Makary MS. Evolving and novel applications of artificial intelligence in cancer imaging. Cancers. 2025;17(9):1510. doi:10.3390/cancers17091510
99. Yin C, Zhang H, Du J, Zhu Y, Zhu H, Yue H. Artificial intelligence in imaging for liver disease diagnosis. Frontiers in Medicine. 2025;12:1591523. doi:10.3389/fmed.2025.1591523
100. Grapă C, Mocan T, Mocan LP, et al. Turning the Tide-artificial intelligence in the evolving landscape of liver cancer. Cancers. 2025;17(18):3003. doi:10.3390/cancers17183003
101. Wang Y, Chi S, Tian Y, et al. Construction of an artificially intelligent model for accurate detection of HCC by integrating clinical, radiological, and peripheral immunological features. Int J Surg. 2025;111(4):2942–2952. doi:10.1097/JS9.0000000000002281
102. Teng X, Luo QN, Chen YD, Peng T. From texture analysis to artificial intelligence: global research landscape and evolutionary trajectory of radiomics in hepatocellular carcinoma. Discov Oncol. 2025;16(1):1694. doi:10.1007/s12672-025-03620-x
© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
